Siro Bagnoli
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Redefining remission targets in inflammatory bowel disease: The rise of ultrasound remission.
Journal: Current opinion in pharmacology
Published: July 02, 2025
The use of International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) in patients with ulcerative colitis: applicability and comparison with other ultrasound scores.
Journal: Journal of Crohn's & colitis
Published: March 24, 2025
Correlation of Ultrasound Scores with Endoscopic Activity in Crohn's Disease: A Prospective Exploratory Study.
Journal: Journal of Crohn's & colitis
Published: April 06, 2023
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey.
Journal: Journal of digestive diseases
Published: April 28, 2022
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease.
Journal: European journal of gastroenterology & hepatology
Published: January 20, 2022
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.
Journal: Inflammatory bowel diseases
Published: November 28, 2020
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study.
Journal: Annals of gastroenterology
Published: July 29, 2020
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey.
Journal: European journal of gastroenterology & hepatology
Published: April 14, 2020
Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center.
Journal: Journal of digestive diseases
Published: January 11, 2019
Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centers.
Journal: Journal of digestive diseases
Published: March 24, 2018
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 03, 2017
Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: June 24, 2016
Last Updated: 09/26/2026